Exploration of Olfaction and ChiPSO in Pediatric Cystic Fibrosis

被引:0
|
作者
Saak, Tiana M. [1 ]
Tervo, Jeremy P. [1 ]
Moore, Brandon M. [1 ]
Wang, Alicia S. [1 ]
DiMango, Emily [2 ]
Sadeghi, Hossein [3 ]
Gudis, David A. [1 ,4 ]
Overdevest, Jonathan B. [1 ,4 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Div Pulm Allergy & Crit Care Med, New York Presbyterian, Irving Med Ctr, New York, NY 10032 USA
[3] Columbia Univ, Irving Med Ctr, Div Pediat Pulmonol, New York Presbyterian, New York, NY 10032 USA
[4] Columbia Univ, Irving Med Ctr, Dept Otolaryngol Head & Neck Surg, New York Presbyterian, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; children; olfaction; ChiPSO; olfactory importance; quality of life; OLDER-ADULTS; DYSFUNCTION; DEPRESSION; IMPAIRMENT; PREVALENCE; CHILDREN; QUALITY; LIFE;
D O I
10.3390/jcm14082583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Olfactory dysfunction (OD) is a common symptom among people with cystic fibrosis (PwCF) and contributes to environmental safety concerns, nutritional challenges, and an overall diminished quality of life. OD is perceived to progress along the lifespan in PwCF, often due to worsening sinonasal disease. Among children with cystic fibrosis (CwCF), OD is poorly characterized as limited resources and tolerance contribute to challenges in psychophysical olfactory evaluation among pediatric populations. The Children's Personal Significance of Olfaction (ChiPSO) questionnaire was recently proposed as a tool to assess olfaction and the importance of olfactory stimulation among children. This pilot study aimed to evaluate the utility of ChiPSO among a cohort of ethnically diverse CwCF. Methods: Individuals aged 7-17 with physician-diagnosed CF were asked to complete questionnaires, including ChiPSO and the brief questionnaire on olfactory dysfunction (bQOD-NS), prior to undergoing psychophysical olfactory evaluation with the U-Sniff Identification test. Potential associations between questionnaires and olfactory performance, pulmonary function, and demographic characteristics were evaluated using Pearson and Spearman correlations, independent-sample t-tests, Wilcoxon rank sum tests, and multiple linear regression. Results: U-Sniff Identification score positively correlated with the overall ChiPSO total score [r(13) = 0.640, p = 0.010] and its environmental subdomain score [r(13) = 0.774, p < 0.001], though not with the food subdomain [r(13) = 0.450, p = 0.093], the social subdomain [r(13) = 0.343, p = 0.2], or bQOD-NS score [r(11) = -0.125, p = 0.7]. Hispanic ethnicity is associated with ChiPSO (p = 0.041). Conclusions: In this preliminary study, olfactory importance increases with olfactory function among an ethnically diverse sample of CwCF, with a preferential influence of olfactory function on personal importance of environmental olfactory information. While these results should be interpreted with limitations imposed by the pilot nature of our sample size, our pilot data highlights associations with early adolescent development of importance of olfaction that can be disrupted in the setting of progressive disease among CwCF.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Prognosis and treatment of 46 Chinese pediatric cystic fibrosis patients
    Chen, Qionghua
    Shen, Yuelin
    Xu, Hui
    Tang, Xiaolei
    Yang, Haiming
    Zhao, Shunying
    BMC PEDIATRICS, 2021, 21 (01)
  • [42] Neutropenia associated with the use of cefepime in pediatric patients with cystic fibrosis
    Hernandez, Ruben
    Delpiano, Luis
    Amador, Jorge
    Arias, Mariana
    Carrasco Delgado, Juan
    REVISTA CHILENA DE INFECTOLOGIA, 2019, 36 (01): : 112 - 114
  • [43] Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis
    Arrieta, Antonio C.
    Ang, Jocelyn Y.
    Zhang, Zufei
    Larson, Kajal B.
    Yu, Brian
    Johnson, Matthew G.
    Rhee, Elizabeth G.
    Feng, Ed H.
    Rizk, Matthew L.
    PEDIATRIC PULMONOLOGY, 2020, 55 (08) : 2025 - 2032
  • [44] Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients
    Sobin, Lindsay
    Kawai, Kosuke
    Irace, Alexandria L.
    Gergin, Ozgul
    Cunningham, Michael
    Sawicki, Gregory S.
    Adil, Eelam A.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (02) : 302 - 308
  • [45] Quality of life assessment in patients with cystic fibrosis by means of the Cystic Fibrosis Questionnaire
    Cohen, Milena Antonelli
    Goncalves de Oliveira Ribeiro, Maria Angela
    Ribeiro, Antonio Fernando
    Ribeiro, Jose Dirceu
    Morcillo, Andre Moreno
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (02) : 184 - 192
  • [46] Cystic Fibrosis Transitions of Care Lessons Learned and Future Directions for Cystic Fibrosis
    Okumura, Megumi J.
    Kleinhenz, Mary Ellen
    CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 119 - +
  • [47] Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations
    Davis, Chelsea S.
    Faino, Anna, V
    Onchiri, Frankline
    Gibson, Ronald L.
    Merjaneh, Lina
    Ramsey, Bonnie W.
    Rosenfeld, Margaret
    Cogen, Jonathan D.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (01) : 75 - 82
  • [48] The Burden of Disease in Pediatric Non-Cystic Fibrosis Bronchiectasis
    Kapur, Nitin
    Masters, I. Brent
    Newcombe, Peter
    Chang, Anne B.
    CHEST, 2012, 141 (04) : 1018 - 1024
  • [49] Sleep-disordered breathing in cystic fibrosis pediatric subjects
    Lumertz, Magali Santos
    Pinto, Leonardo Araujo
    SLEEP SCIENCE, 2019, 12 (03) : 165 - 170
  • [50] A systematic review of attention-deficit/hyperactivity disorder in people living with cystic fibrosis
    Power, Hilary
    Shivak, Shelby
    Kim, Jinsoo
    Wright, Kristi
    PEDIATRIC PULMONOLOGY, 2024, 59 (04) : 825 - 833